[A trial of rabies vaccine treatment of patients with glioblastoma multiforme].
Active nonspecific immunotherapy with antirabies vaccine was conducted for the management of glioblastoma multiforme. As a result a statistically significant prolongation of the patients' survival occurred as compared with the control group. No complications developed when contraindications for applying the vaccine were taken into account.
Filipov
F V
FV
D001932:Brain Neoplasms / Q000401:mortality / Q000628:therapy*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005909:Glioblastoma / Q000401:mortality / Q000628:therapy*; D006801:Humans; D011819:Rabies Vaccines / Q000627:therapeutic use*; D014613:Vaccines, Attenuated / Q000627:therapeutic use
D011819:Rabies Vaccines; D014613:Vaccines, Attenuated
Popytka lecheniia antirabicheskoĭ vaktsinoĭ bol'nykh s mul'tiformnoĭ glioblastomoĭ.